Citigroup raised its rating on Innate Pharma stock, which trades on the Nasdaq exchange. Leerink Partners also upgraded the rating. MarketBeat aggregates the rating data.

The entities involved

• Citigroup →

  American investment bank and financial services corporation

  • Citigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Mon 11:05
  • Citigroup and Jefferies Financial Group downgraded the stock rating for Yara International on June 26, 2026.Mon 10:14
• Leerink partners →

  U.S. investment bank

  • Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
  • A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• MarketBeat →

  American personal finance blog

  • MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15
  • MarketBeat is reporting analyst ratings for Shell and Targa Resources.Mon 16:30

Related events

• Penguin Solutions, Inc. stock traded on Nasdaq, with Citigroup providing rating updates and legal filings made with the SEC.Jul 28
• Citigroup provided analyst ratings and reports for ServiceTitan stock, which trades on Nasdaq.Aug 25
• MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.Sep 15
• Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.Jun 28
• MarketBeat aggregated average rating data while Citigroup provided a market outperform rating for Asana.Sep 15